Getting to the heart

Did you know?
The heart is the most commonly affected organ in Fabry disease.
62% of all Fabry disease deaths are heart-related.
4DMT is developing a novel gene therapy
that may treat Fabry heart disease by producing protein similar to enzyme replacement therapy from within the heart, in addition to other affected organs such as the kidney, liver, etc.